AptarGroup, Inc. (NYSE:ATR) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain OfficersItem 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
(b) Retirement of Director
On January 18, 2018, King Harris, who serves as the Chairman of the Board of Directors (the “Board”) of AptarGroup, Inc. (the “Company”), announced that he will be retiring from the Board effective at the Company’s Annual Meeting of Stockholders on May 2, 2018. The Board has elected current director George Fotiades to replace Mr. Harris as Chairman upon his retirement.
(d) Election of New Directors
Also on January 18, 2018, the Board appointed Craig Owens and Jesse Wu as directors, effective February 1, 2018. Mr. Owens will serve as a director for a term expiring at the Company’s 2020 Annual Meeting and will also serve on the Company’s Audit Committee. Mr. Wu will serve as a director for a term expiring at the Company’s 2018 Annual Meeting and will also serve on the Company’s Compensation and Management Development Committee. The Board has determined that each of Messrs. Owens and Wu is an “independent director” under New York Stock Exchange rules and that Mr. Owens is an “audit committee financial expert” as defined by the Securities and Exchange Commission (the “SEC”).
Mr. Owens, 63, is the former Chief Financial Officer and Administrative Officer of Campbell Soup Company. In addition, he was the Chairman of the company’s Operating Committee.
Mr. Wu, 61, advises private equity firms and previously held senior leadership roles at Johnson & Johnson including Chairman of Johnson & Johnson China and Worldwide Chairman of the company’s Consumer Healthcare Division.
Messrs. Owens’ and Wu’s compensation for service on the Board and its committees will be consistent with that of other non-employee directors of the Company, as described in the Company’s definitive proxy statement with respect to its 2017 Annual Meeting filed with the SEC on March 22, 2017. There are no other arrangements or understandings between either Messrs. Owens or Wu and any other person to which they were appointed as directors, and Messrs. Owens and Wu are not a party to any transaction with the Company that would require disclosure under Item 404(a) of Regulation S-K.
About AptarGroup, Inc. (NYSE:ATR)
AptarGroup, Inc. is a provider of a range of packaging, dispensing and sealing solutions, primarily for the beauty, personal care, home care, prescription drug, consumer healthcare, injectables, food and beverage markets. The Company has manufacturing facilities located in North America, Europe, Asia and South America. The Company’s segments include Beauty + Home, Pharma and Food + Beverage. It offers various dispensing and sealing solutions. Its primary products are dispensing pumps, closures and aerosol valves. It also manufactures and sells elastomer primary packaging components, which include stoppers for infusion, antibiotic, lyophilization and diagnostic vials. The Company’s elastomer components also include pre-filled syringe components, such as plungers, needle shields, tip caps and cartridges, as well as dropper bulbs and disposable syringe plungers.
